Doxycycline Hyclate Patent Expiration

Doxycycline Hyclate is Used for treating or preventing infections caused by susceptible bacteria. It was first introduced by Pfizer Laboratories Div Pfizer Inc in its drug Vibramycin on Approved Prior to Jan 1, 1982. Other drugs containing Doxycycline Hyclate are Acticlate Cap, Atridox, Periostat, Acticlate, Doryx, Doryx Mpc, Lymepak, Vibra-Tabs. 66 different companies have introduced drugs containing Doxycycline Hyclate.


Doxycycline Hyclate Patents

Given below is the list of patents protecting Doxycycline Hyclate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Doryx US6958161 Modified release coated drug preparation Dec 15, 2022

(Expired)

Mayne Pharma
Doryx US8715724 Tabletting process Feb 03, 2028 Mayne Pharma
Doryx Mpc US6958161 Modified release coated drug preparation Dec 15, 2022

(Expired)

Mayne Pharma
Doryx Mpc US8715724 Tabletting process Feb 03, 2028 Mayne Pharma
Doryx Mpc US9295652 Controlled release doxycycline Oct 23, 2034 Mayne Pharma
Doryx Mpc US9446057 Controlled release doxycycline Dec 23, 2034 Mayne Pharma
Doryx Mpc US9511031 Controlled release doxycycline Oct 23, 2034 Mayne Pharma


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Doxycycline Hyclate Generics

Several generic applications have been filed for Doxycycline Hyclate. The first generic version for Doxycycline Hyclate was by Rachelle Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Hainan Poly Pharm Co Ltd and was approved on Jun 21, 2024.

Given below is the list of companies who have filed for Doxycycline Hyclate generic.


1. HERITAGE PHARMA

Heritage Pharma Labs Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heritage Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Discontinued ORAL N/A May 13, 2005


2. CHANGZHOU PHARM

Changzhou Pharmaceutical Factory has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Changzhou Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Oct 9, 2019


3. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Doxycycline Hyclate. This eq 100mg base/vial version comes by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Aug 21, 2012


4. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Oct 24, 2022


5. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Apr 15, 2024
EQ 50MG BASE capsule Discontinued ORAL N/A Dec 10, 2020


6. LUPIN

Lupin Inc has filed for 8 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 120MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 80MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 200MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 150MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 50MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 60MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 75MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023
EQ 100MG BASE tablet, delayed release Discontinued ORAL N/A Aug 11, 2023


7. HERITAGE PHARMS

Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 4 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heritage Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 150MG BASE tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 100MG BASE tablet, delayed release Prescription ORAL AB Apr 30, 2013
EQ 200MG BASE

(reference standard)

tablet, delayed release Prescription ORAL AB Nov 13, 2018


8. TEVA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. All of these versions come by the name DOXY-LEMMON. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Mar 15, 1985
EQ 50MG BASE capsule Discontinued ORAL N/A Aug 23, 1984


9. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Mar 29, 1982
EQ 100MG BASE tablet Discontinued ORAL N/A Apr 7, 1986


10. INTERPHARM

Interpharm Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Interpharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Sep 2, 1988
EQ 50MG BASE capsule Discontinued ORAL N/A Sep 2, 1988


11. AMNEAL PHARMS

Amneal Pharmaceuticals Holdings Gmbh has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Jun 27, 2016


12. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Nov 22, 2021
EQ 100MG BASE capsule Discontinued ORAL N/A Nov 22, 2021


13. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet Prescription ORAL AB Apr 15, 2019
EQ 75MG BASE tablet Prescription ORAL AB Apr 15, 2019


14. ACELLA

Acella Pharmaceuticals Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Acella.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Mar 16, 2020


15. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE tablet Prescription ORAL AB Sep 14, 2021
EQ 100MG BASE tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 20MG BASE tablet Prescription ORAL AB Mar 3, 2020
EQ 150MG BASE tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 75MG BASE tablet, delayed release Prescription ORAL AB Jan 3, 2022
EQ 200MG BASE tablet, delayed release Prescription ORAL AB Jan 3, 2022


16. NOVEL LABS INC

Novel Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Sep 6, 2017


17. TORRENT

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet Discontinued ORAL N/A Apr 15, 2024
EQ 75MG BASE tablet Discontinued ORAL N/A Apr 15, 2024


18. HIKMA INTL PHARMS

Hikma International Pharmaceuticals Llc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Jul 2, 2003
EQ 50MG BASE capsule Prescription ORAL AB Nov 7, 1984
EQ 20MG BASE capsule Discontinued ORAL N/A May 13, 2005


19. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. All of these versions come by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL injectable Discontinued INJECTION N/A Mar 9, 1988
EQ 100MG BASE/VIAL injectable Discontinued INJECTION N/A Mar 9, 1988


20. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Mar 31, 1983
EQ 50MG BASE tablet Discontinued ORAL N/A Mar 31, 1983


21. RANBAXY

Ranbaxy Pharmaceuticals Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Ranbaxy.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Dec 23, 1983
EQ 50MG BASE capsule Discontinued ORAL N/A Dec 23, 1983


22. RACHELLE

Rachelle Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. This eq 100mg base/vial version comes by the name DOXYCHEL HYCLATE. Given below are the details of the strengths of this generic introduced by Rachelle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


23. HALSEY

Halsey Drug Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Halsey.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A May 24, 1985
EQ 100MG BASE capsule Discontinued ORAL N/A May 24, 1985


24. SUPERPHARM

Superpharm Corp has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Superpharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Oct 31, 1984
EQ 100MG BASE tablet Discontinued ORAL N/A Feb 20, 1985


25. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Prescription ORAL AB Sep 27, 2017
EQ 150MG BASE tablet Prescription ORAL AB Sep 27, 2017
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Mar 14, 2024


26. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB May 31, 2018
EQ 50MG BASE capsule Prescription ORAL AB May 31, 2018


27. PLIVA

Pliva Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Pliva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule, coated pellets Discontinued ORAL N/A Jun 30, 1992


28. AVET LIFESCIENCES

Avet Lifesciences Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Nov 9, 2018


29. ZHEJIANG YONGTAI

Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Mar 31, 2020
EQ 50MG BASE capsule Discontinued ORAL N/A Mar 31, 2020


30. PHARMOBEDIENT

Pharmobedient Consulting Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Pharmobedient.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Mar 10, 2021


31. HAINAN POLY

Hainan Poly Pharm Co Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Hainan Poly.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL injectable Prescription INJECTION AP Jun 21, 2024
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Jun 21, 2024


32. MUTUAL PHARM

Mutual Pharmaceutical Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Mutual Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Jan 28, 1983
EQ 50MG BASE capsule Prescription ORAL AB Jul 10, 1986


33. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Doxycycline Hyclate. Out of these eq 200mg base/vial version comes by the name DOXYCYCLINE, eq 100mg base/vial version comes by the name DOXYCYCLINE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL injectable Prescription INJECTION AP Sep 28, 2017
EQ 100MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Sep 28, 2017
EQ 75MG BASE tablet, delayed release Discontinued ORAL N/A Dec 21, 2018
EQ 100MG BASE tablet, delayed release Discontinued ORAL N/A Dec 21, 2018
EQ 150MG BASE tablet, delayed release Discontinued ORAL N/A Dec 21, 2018


34. HEATHER

Heather Drug Co Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Heather.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Dec 7, 1983
EQ 50MG BASE capsule Discontinued ORAL N/A Dec 7, 1983


35. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Feb 16, 1989
EQ 200MG BASE/VIAL injectable Prescription INJECTION AP Feb 16, 1989


36. LARKEN LABS

Larken Laboratories Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Larken Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Prescription ORAL AB Feb 28, 2006


37. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Prescription ORAL AB Jun 14, 2017
EQ 150MG BASE tablet Prescription ORAL AB Jun 14, 2017


38. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 4 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet, delayed release Prescription ORAL AB Dec 14, 2011
EQ 100MG BASE tablet, delayed release Prescription ORAL AB Dec 14, 2011
EQ 200MG BASE tablet, delayed release Prescription ORAL AB May 22, 2018
EQ 50MG BASE tablet, delayed release Prescription ORAL AB May 22, 2018


39. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Discontinued ORAL N/A Oct 6, 2017
EQ 150MG BASE tablet Discontinued ORAL N/A Oct 6, 2017


40. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet, delayed release Discontinued ORAL N/A Feb 8, 2012


41. PRAXGEN

Praxgen Pharmaceuticals Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Praxgen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Discontinued ORAL N/A Mar 30, 2022


42. CHARTWELL

Chartwell Scheduled Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Prescription ORAL AB Sep 11, 1984
EQ 50MG BASE tablet Prescription ORAL AB Jul 27, 2021


43. BAUSCH

Bausch Health Us Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Bausch.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule, delayed release Discontinued ORAL N/A Dec 21, 2005
EQ 75MG BASE capsule, delayed release Discontinued ORAL N/A Dec 21, 2005


44. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE capsule Discontinued ORAL N/A Sep 24, 2018
EQ 100MG BASE capsule Discontinued ORAL N/A Sep 24, 2018
EQ 150MG BASE tablet Prescription ORAL AB Jun 1, 2020
EQ 75MG BASE tablet Prescription ORAL AB Jun 1, 2020


45. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Jul 10, 1986
EQ 50MG BASE capsule Prescription ORAL AB Jul 10, 1986
EQ 20MG BASE tablet Prescription ORAL AB May 13, 2005


46. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet, delayed release Discontinued ORAL N/A Dec 28, 2010
EQ 100MG BASE tablet, delayed release Discontinued ORAL N/A Dec 28, 2010


47. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Out of these eq 200mg base/vial version comes by the name DOXY 200, eq 100mg base/vial version comes by the name DOXY 100. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Dec 9, 1983
EQ 100MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Dec 9, 1983


48. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet, delayed release Prescription ORAL AB Nov 15, 2016
EQ 200MG BASE tablet, delayed release Prescription ORAL AB Nov 15, 2016
EQ 50MG BASE tablet, delayed release Prescription ORAL AB Feb 19, 2019


49. PVT FORM

Private Formulations Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Pvt Form.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Jul 24, 1986
EQ 50MG BASE capsule Discontinued ORAL N/A Jul 24, 1986


50. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Feb 15, 1983


51. RISING

Rising Pharma Holding Inc has filed for 6 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE tablet Discontinued ORAL N/A Oct 5, 2020
EQ 100MG BASE tablet, delayed release Discontinued ORAL N/A Dec 28, 2010
EQ 80MG BASE tablet, delayed release Discontinued ORAL N/A Apr 29, 2016
EQ 200MG BASE tablet, delayed release Discontinued ORAL N/A May 19, 2016
EQ 50MG BASE tablet, delayed release Discontinued ORAL N/A May 23, 2016
EQ 150MG BASE tablet Discontinued ORAL N/A Oct 5, 2020


52. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

(reference standard)

tablet Prescription ORAL AB Nov 10, 2005


53. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Prescription INJECTION AP Apr 12, 2023


54. WARNER CHILCOTT

Warner Chilcott Div Warner Lambert Co has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Warner Chilcott.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Dec 5, 1985
EQ 50MG BASE capsule Discontinued ORAL N/A Dec 5, 1985


55. CARIBE HOLDINGS

Caribe Holdings Cayman Co Ltd Dba Puracap Caribe has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Caribe Holdings.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

(reference standard)

tablet Prescription ORAL AB Nov 8, 1982
EQ 50MG BASE tablet Prescription ORAL AB Oct 5, 1983


56. EPIC PHARMA LLC

Epic Pharma Llc has filed for 3 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE tablet Prescription ORAL AB May 13, 2005
EQ 75MG BASE tablet Prescription ORAL AB Dec 16, 2020
EQ 150MG BASE tablet Prescription ORAL AB Dec 16, 2020


57. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE/VIAL injectable Discontinued INJECTION N/A Dec 7, 2022


58. PAR PHARM

Par Pharmaceutical Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Par Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE capsule Discontinued ORAL N/A Dec 22, 1983
EQ 50MG BASE capsule Discontinued ORAL N/A Oct 19, 1984


59. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Doxycycline Hyclate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Feb 2, 1983
EQ 50MG BASE capsule Prescription ORAL AB Oct 13, 1982